About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) today called on the Office of the United States Trade Representative (USTR) to defend American biopharmaceutical innovators and jobs by ending market access and intellectual property barriers in 24 leading economies around the world. In its submission for USTR’s 2020 Special 301 Report, PhRMA called on the Trump administration to address discriminatory market access practices abroad that free ride on American innovation and put U.S. jobs and exports at risk.
PhRMA Special 301 Submission 2020 image
Report
Intellectual Property
PhRMA Special 301 Submission 2020
PhRMA Special 301 Submission 2020 image